Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Ames

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|December 1, 1982
Pharmacokinetic study of indicine N-oxide in pediatric cancer patientsM M Ames, J S Miser, W A Smithson, et al.
Journal of Pediatric Hematology/Oncology|February 25, 1999
Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate modelS L Berg, J Reid, K Godwin, et al.
Molecular Pharmacology|February 29, 2000
Effect of 6-aminonicotinamide and other protein synthesis inhibitors on formation of platinum-DNA adducts and cisplatin sensitivityI I Budihardjo, S A Boerner, S Eckdahl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeksS R Alberts, C Erlichman, J M Reid, et al.
Investigational New Drugs|February 1, 1991
Phase I-II study of pibenzimol hydrochloride (NSC 322921) in advanced pancreatic carcinomaS R Patel, L K Kvols, J Rubin, et al.
The Hospice Journal|January 1, 1993
Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancerT Davis, A W Miser, C L Loprinzi, et al.
Science (New York, N.Y.)|December 21, 1990
Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndromeA N Mayeno, F Lin, C S Foote, et al.
Cancer Research|July 1, 1990
Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole)M M Ames, C L Loprinzi, J M Collins, et al.
Cancer|February 1, 1981
Activity of indicine N-oxide in refractory acute leukemiaL Letendre, W A Smithson, G S Gilchrist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factorR M Goldberg, J M Reid, M M Ames, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|December 1, 1982
Pharmacokinetic study of indicine N-oxide in pediatric cancer patientsM M Ames, J S Miser, W A Smithson, et al.
Journal of Pediatric Hematology/Oncology|February 25, 1999
Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate modelS L Berg, J Reid, K Godwin, et al.
Molecular Pharmacology|February 29, 2000
Effect of 6-aminonicotinamide and other protein synthesis inhibitors on formation of platinum-DNA adducts and cisplatin sensitivityI I Budihardjo, S A Boerner, S Eckdahl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeksS R Alberts, C Erlichman, J M Reid, et al.
Investigational New Drugs|February 1, 1991
Phase I-II study of pibenzimol hydrochloride (NSC 322921) in advanced pancreatic carcinomaS R Patel, L K Kvols, J Rubin, et al.
The Hospice Journal|January 1, 1993
Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancerT Davis, A W Miser, C L Loprinzi, et al.
Science (New York, N.Y.)|December 21, 1990
Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndromeA N Mayeno, F Lin, C S Foote, et al.
Cancer Research|July 1, 1990
Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole)M M Ames, C L Loprinzi, J M Collins, et al.
Cancer|February 1, 1981
Activity of indicine N-oxide in refractory acute leukemiaL Letendre, W A Smithson, G S Gilchrist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factorR M Goldberg, J M Reid, M M Ames, et al.
Pageof 9